A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma.
Kessler ER, Callihan E, Hu J, Eule C, Srivastava G, Kemme DJ, Iruku P, Rana V, Moore J, Schuster SR, Amirault M, Flaig TW, Lam ET.
Kessler ER, et al.
Cancer Res Commun. 2023 Jun 8;3(6):1004-1012. doi: 10.1158/2767-9764.CRC-23-0060. eCollection 2023 Jun.
Cancer Res Commun. 2023.
PMID: 37377613
Free PMC article.
Clinical Trial.